Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 7, 2006, Pages 781-783

  Van Den Akker, E S A ^a   Oepkes, D ^a   Brand, A ^a   Kanhai, H H H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloimmune thrombocytopenia; Caesarean section; HPA 1a; Immunoglobulins; Intracranial haemorrhage

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ADULT; ALLOIMMUNITY; ALLOIMMUNIZATION; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; CESAREAN SECTION; EXPERIENCE; FEMALE; FETUS BLOOD; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RARE DISEASE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VAGINAL DELIVERY;

ADULT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; PLATELET COUNT; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA;

EID: 33745504565     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00993.x     Document Type: Article

References (18)

1. Radder CM, Brand A, Kanhai HHH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003 84 : 318 25.
2. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001 41 : 45 55.
3. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 1996 174 : 1414 23.
4. Kaplan C, Murphy MF, Kroll H, Waters AH. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids - more questions than answers. European Working Group on FMAIT. Br J Haematol 1998 100 : 62 5.
5. Reznikoff-Etievant MF. Management of alloimmune neonatal and antenatal thrombocytopenia. Vox Sang 1988 55 : 193 201.
6. Radder CM, Brand A, Kanhai HHH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001 185 : 683 8.
7. Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P, van Geijn H, et al. Maternal mortality after cesarean section in The Netherlands. Acta Obstet Gynecol Scand 1997 76 : 332 4.
8. Lydon-Rochelle M, Holt VL, Martin DP, Easterling TR. Association between method of delivery and maternal rehospitalization. JAMA 2000 283 : 2411 16.
9. Ham van MAPC, Dongen van PWJ, Mulder J. Maternal consequences of caesarean section: a retrospective study of intraoperative and postoperative maternal complications of caesarean section during a 10-year period. Eur J Obstet Gynecol Reprod Biol 1997 74 : 1 6.
10. Greene MF. Vaginal delivery after cesarean section - is the risk acceptable? N Engl J Med 2001 345 : 54 5.
11. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997 177 : 210 14.
12. Tongsong T, Wanapirak C, Kunavikatikul C, Sirirchotiyakul S, Piyamongkol W, Chanprapaph P. Fetal loss rate associated with cordocentesis at midgestation. Am J Obstet Gynecol 2001 184 : 719 23.
13. Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005 192 : 171 7.
14. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997 337 : 22 6.
15. Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K. Antenatal management of severe feto/maternal alloimmune thrombocytopenia ± HLA incompatibility may affect responses to fetal thrombocyte transfusions. Blood 1993 81 : 2174 9.
16. Murphy MF, Waters AH, Doughty A, Hambley H, Mibashan S, Nicolaides K, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transfus Med 1994 4 : 281 92.
17. Sainio S, Teramo K, Kekomäki R. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Transfus Med 1999 9 : 321 30.
18. Kroll H, Kiefel V, Giers O, Bald R, Hoch J, Hanfland P, et al. Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfus Med 1994 4 : 293 6.